UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo

Proceedings of the National Academy of Sciences - PNAS, 2008-07, Vol.105 (30), p.10519-10524

2008

Volltextzugriff (PDF)

Acute lymphoblastic leukemia of the central nervous system: on the role of PBX1

Haematologica (Roma), 2017-04, Vol.102 (4), p.611-613

2017

Volltextzugriff (PDF)

When the bond breaks - targeting adhesion of leukemia cells to the meninges

Haematologica (Roma), 2020-08, Vol.105 (8), p.1991-1993

2020

Volltextzugriff (PDF)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer

Frontiers in immunology, 2023-09, Vol.14, p.1240275-1240275

2023

Volltextzugriff (PDF)

The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system

Haematologica (Roma), 2017-02, Vol.102 (2), p.346-355

2017

Volltextzugriff (PDF)

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

Annals of hematology, 2023-03, Vol.102 (3), p.669-672

2023

Volltextzugriff (PDF)

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

Frontiers in immunology, 2022-10, Vol.13, p.929339-929339

2022

Volltextzugriff (PDF)

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions

Cancer science, 2021-08, Vol.112 (8), p.3029-3040

2021

Volltextzugriff (PDF)

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab

Frontiers in immunology, 2022-08, Vol.13, p.949140-949140

2022

Volltextzugriff (PDF)

In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets

Nature communications, 2021-09, Vol.12 (1), p.5655-5655, Article 5655

2021

Volltextzugriff (PDF)

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia

Nature communications, 2020-06, Vol.11 (1), p.3194-12, Article 3194

2020

Volltextzugriff (PDF)

Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data

Cancer and metastasis reviews, 2020-03, Vol.39 (1), p.173-187

2020

Volltextzugriff (PDF)

Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia

Oncoimmunology, 2018-01, Vol.7 (8), p.e1448331-e1448331

2018

Volltextzugriff (PDF)

Outcome for Pediatric Adreno-Cortical Tumors Is Best Predicted by the COG Stage and Five-Item Microscopic Score-Report from the German MET Studies

Cancers, 2022-12, Vol.15 (1), p.225

2022

Volltextzugriff (PDF)

The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A -rearranged acute lymphoblastic leukemia

Haematologica (Roma), 2017-11, Vol.102 (11), p.e438-e442

2017

Volltextzugriff (PDF)

TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling

Nature cell biology, 2013-11, Vol.15 (11), p.1351-1361

2013

Volltextzugriff (PDF)

Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade

HemaSphere, 2024-02, Vol.8 (2), p.e48-n/a

2024

Volltextzugriff (PDF)

AP‐1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T‐ALL

HemaSphere, 2023-09, Vol.7 (9), p.e945-n/a

2023

Volltextzugriff (PDF)

Larotrectinib in TRK fusion–positive pediatric B-cell acute lymphoblastic leukemia

Blood advances, 2019-11, Vol.3 (22), p.3499-3502

2019

Volltextzugriff (PDF)

CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia

Communications biology, 2021-01, Vol.4 (1), p.73-6, Article 73

2021

Volltextzugriff (PDF)

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B‐cell Precursor Acute Lymphoblastic Leukemia

HemaSphere, 2022-08, Vol.6 (8), p.e754-n/a

2022

Volltextzugriff (PDF)

Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL

Blood, 2022-07, Vol.140 (1), p.45-57

2022

Volltextzugriff (PDF)

Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy

Cancer research (Chicago, Ill.), 2009-02, Vol.69 (4), p.1545-1552

2009

Volltextzugriff (PDF)

Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia

Blood, 2019-08, Vol.134 (8), p.713-716

2019

Volltextzugriff (PDF)

“Mouse‐MRD” in central nervous system acute lymphoblastic leukaemia: assessing bone marrow minimal residual disease using a xenograft model – from bedside to the bench and back again

British journal of haematology, 2018-11, Vol.183 (4), p.686-688

2018

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(62)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(44)
Humans
(30)
Hematology
(25)
Oncology
(16)
Animals
(15)
Mice
(13)
Child
(12)
Female
(11)
Tumors
(10)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Pathology
(9)
Acute Lymphoblastic Leukemia
(7)
Leukemia
(7)
Male
(6)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(6)
Prognosis
(6)
Cancer
(5)
Patients
(5)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Metabolism
(5)
Biological And Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo

Acute lymphoblastic leukemia of the central nervous system: on the role of PBX1

When the bond breaks - targeting adhesion of leukemia cells to the meninges

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer

The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab

In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia

Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data

Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia

Outcome for Pediatric Adreno-Cortical Tumors Is Best Predicted by the COG Stage and Five-Item Microscopic Score-Report from the German MET Studies

The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A -rearranged acute lymphoblastic leukemia

TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling

Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade

AP‐1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T‐ALL

Larotrectinib in TRK fusion–positive pediatric B-cell acute lymphoblastic leukemia

CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B‐cell Precursor Acute Lymphoblastic Leukemia

Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL

Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy

Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia

“Mouse‐MRD” in central nervous system acute lymphoblastic leukaemia: assessing bone marrow minimal residual disease using a xenograft model – from bedside to the bench and back again

Suchergebnisse filtern